MARK S KIPNES
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SAN ANTONIO, TX NPI 1376501965
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism TX PFIZER INC. All categories
General Payments — all program years on this page
$33,000.81
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,390
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,621.23 across 87 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,121.23 | 86 |
| Consulting Fee | $500.00 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $513.55 | 2 |
| Ascensia Diabetes Care US Inc. | $433.68 | 7 |
| Lilly USA, LLC | $228.19 | 12 |
| Novo Nordisk AS | $214.67 | 11 |
| Medtronic, Inc. | $207.71 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $176.87 | 9 |
| BETA BIONICS, INC. | $162.00 | 3 |
| Corcept Therapeutics | $147.13 | 6 |
| RECORDATI_RARE_DISEASES_INC. | $121.40 | 7 |
| Radius Health, Inc. | $78.06 | 5 |
| Amgen Inc. | $58.61 | 3 |
| Abbott Laboratories | $39.96 | 6 |
| Bayer HealthCare Pharmaceuticals Inc. | $35.88 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.94 | 2 |
| MannKind Corporation | $33.21 | 2 |
| CeQur Corporation | $33.10 | 1 |
| Kyowa Kirin, Inc. | $25.09 | 1 |
| Neurocrine BioSciences, Inc. | $23.30 | 1 |
| Almatica Pharma Inc. | $21.96 | 1 |
| Xeris Pharmaceuticals, Inc. | $18.35 | 1 |
| SANOFI-AVENTIS U.S. LLC | $13.57 | 1 |
By program year
Records — PY2024 (87)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.